Met Life Investment Management, LLC Clear Point Neuro, Inc. Transaction History

Met Life Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.25 - $6.73 $64,333 - $82,469	-12,254 Closed	0 $0
Q1 2024 May 14, 2024	BUY	$6.03 - $7.86 $73,891 - $96,316	12,254 New	12,254 $83,000
Q3 2023 May 09, 2024	BUY	$5.01 - $7.09 $61,392 - $86,880	12,254 New	12,254 $61,000
Q2 2023 Apr 29, 2024	BUY	$6.54 - $10.58 $80,141 - $129,647	12,254 New	12,254 $88,000
Q2 2023 Aug 10, 2023	BUY	$6.54 - $10.58 $80,141 - $129,647	12,254 New	12,254 $88,000
Q4 2021 Feb 15, 2022	SELL	$11.08 - $18.86 $85,548 - $145,618	-7,721 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$16.58 - $22.25 $128,014 - $171,792	7,721 New	7,721 $137,000
Q2 2021 May 17, 2024	SELL	$17.23 - $22.77 $78,103 - $103,216	-4,533 Reduced 36.99%	7,721 $147,000
Q2 2021 Jun 21, 2023	BUY	$17.23 - $22.77 $133,032 - $175,807	7,721 New	7,721 $147,000
Q2 2021 Mar 22, 2023	BUY	$17.23 - $22.77 $133,032 - $175,807	7,721 New	7,721 $147,000
Q2 2021 Aug 16, 2021	BUY	$17.23 - $22.77 $133,032 - $175,807	7,721 New	7,721 $147,000

6.84M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $435M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.